Senzatimore Jr Salvatore MD entered the industry of in 1998 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a . For further clarification, the SIC classifies this business under the code 8031 and described it as a . The business provides service to the B2B market.
To acquire more information, please contact Salvatore Senzatimore Jr by calling (561) 659-5466 during business hours. You can also write to the business’ Single Location at 1117 North Olive Avenue # 203, West Palm Beach, Florida FL 33401. You can also visit the company’s website at centerforgiendoscopy.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Senzatimore Jr Salvatore MD |
Representative: | Salvatore Senzatimore Jr |
Place of Business: | 1117 North Olive Avenue # 203, West Palm Beach, FL 33401 |
Contact Number: | (561) 659-5466 |
Website: | centerforgiendoscopy.com |
Type of Service: | |
SIC Number: | 8031 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1998 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Senzatimore Jr Salvatore MD is a company operating from Palm Beach, Florida providing professional and relevant B2B variables. It was founded in 1998 and registered with the SIC code 8031 as , and with the NAICS code 6211110 as .
With a current employee count of 1 to 4, Senzatimore Jr Salvatore MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Salvatore Senzatimore Jr at (561) 659-5466 for related queries, or to locate its Single Location using the coordinates 26.72313,-80.05169.
The Single Location can also be found at the street address 1117 North Olive Avenue # 203 in West Palm Beach, Florida 33401 and can be engaged online through the company website at centerforgiendoscopy.com, the company Twitter , and Facebook page .